Literature DB >> 5294659

Idiopathic diffuse interstitial lung disease. A review of 42 cases.

B H Stack, I W Grant, W J Irvine, M A Moffat.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5294659     DOI: 10.1164/arrd.1965.92.6P1.939

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  9 in total

Review 1.  Pathophysiology of diffuse interstitial lung disease.

Authors:  J M Stinson
Journal:  J Natl Med Assoc       Date:  1974-07       Impact factor: 1.798

2.  Desquamative interstitial pneumonia: relationship to interstitial fibrosis.

Authors:  A S Patchefsky; H L Israel; W S Hoch; G Gordon
Journal:  Thorax       Date:  1973-11       Impact factor: 9.139

3.  [A contribution to the problem of the present status of diffuse progressive pulmonary fibrosis, the Hamman-Rich syndrom].

Authors:  L Levinsky
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1967

4.  The prognosis of cryptogenic fibrosing alveolitis.

Authors:  B H Stack; Y F Choo-Kang; B E Heard
Journal:  Thorax       Date:  1972-09       Impact factor: 9.139

5.  A bovine pulmonary disease resembling human diffuse fibrosing alveolitis.

Authors:  H M Pirie; I E Selman
Journal:  Proc R Soc Med       Date:  1972-11

6.  Diffuse pulmonary fibrosis and hiatus hernia.

Authors:  J E Pearson; R S Wilson
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

7.  Diffuse interstitial pulmonary fibrosis and rheumatoid arthritis.

Authors:  W C Walker; V Wright
Journal:  Ann Rheum Dis       Date:  1969-05       Impact factor: 19.103

8.  Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Correlation of histology at biopsy with prognosis.

Authors:  J G Scadding; K F Hinson
Journal:  Thorax       Date:  1967-07       Impact factor: 9.139

9.  Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway.

Authors:  Yufeng Du; Xiaoyan Hao; Xuejun Liu
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.